Recent Company News

• 07:35 AM ET Aug 11, 2026
  

  Xvivo Perfusion's Heart Assist Transport system receives CE certificate (SEK 295.80, +14.80)

• 03:27 AM ET Aug 03, 2026
  

  XVIVO announces that the FDA has granted the company approval for additional patient enrollment in the Continued Access Protocol (CAP) study of 60 heart transplantations using XVIVO Heart Assist Transport (SEK 270.40, +6.60)

• 10:03 AM ET Jul 22, 2026
  

  Clarification: TorEx PMA decision date was week ago and previously disclosed by the sponsor and FDA

• 09:24 AM ET Jul 22, 2026
  

  Traferox Technologies (private) receives PMA for the TorEx Lung Perfusion System

• 10:57 AM ET Jul 14, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q2 Earnings Guidance

• 10:55 AM ET Jul 14, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q2 Earnings Themes

• 10:55 AM ET Jul 14, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q2 Earnings Q&A

• 04:08 AM ET Jul 14, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:56 AM ET Jul 14, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:33 AM ET Jul 14, 2026
  

  Xvivo Perfusion reports Q2 EPS SEK0.52 vs FactSet SEK0.75 [4 est, SEK0.62-0.99] (SEK 283.00, 0.00)